Methylphenidate is likely less effective than placebo for improving imbalance, walking, and fatigue in people with multiple sclerosis

Michelle Cameron, Garnett McMillan

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
JournalMultiple Sclerosis Journal
DOIs
StateAccepted/In press - Feb 1 2017

Fingerprint

Methylphenidate
Multiple Sclerosis
Walking
Fatigue
Placebos

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

@article{5c74688a42954bfdbe40e4197e33ff43,
title = "Methylphenidate is likely less effective than placebo for improving imbalance, walking, and fatigue in people with multiple sclerosis",
author = "Michelle Cameron and Garnett McMillan",
year = "2017",
month = "2",
day = "1",
doi = "10.1177/1352458517692421",
language = "English (US)",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Methylphenidate is likely less effective than placebo for improving imbalance, walking, and fatigue in people with multiple sclerosis

AU - Cameron, Michelle

AU - McMillan, Garnett

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=85043346578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043346578&partnerID=8YFLogxK

U2 - 10.1177/1352458517692421

DO - 10.1177/1352458517692421

M3 - Article

AN - SCOPUS:85043346578

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

ER -